Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Minafen Spray is a topical analgesic and anti-inflammatory combination spray manufactured by Signature Phytochemical Industries. It is formulated for the rapid relief of musculoskeletal pain, joint pain, backaches, sprains, strains, and sports injuries. The spray contains a combination of dexketoprofen trometamol (a non-steroidal anti-inflammatory drug), linseed oil, methyl salicylate, and menthol. Dexketoprofen trometamol and methyl salicylate act as cyclooxygenase (COX) inhibitors to reduce prostaglandin synthesis and alleviate inflammation and pain. Menthol acts as a counter-irritant and TRPM8 agonist to provide a cooling sensation, while linseed oil helps reduce inflammation and enhances the skin penetration of the active ingredients.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Minafen Spray.